Efficacy and safety of tabalumab, an anti-B-cell-activating...

Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind study

Smolen, Josef S, Weinblatt, Michael E, van der Heijde, Désirée, Rigby, William F C, van Vollenhoven, Ronald, Bingham, Clifton O, Veenhuizen, Melissa, Gill, Anne, Zhao, Fangyi, Komocsar, Wendy J, Bercl
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
74
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2014-207090
Date:
August, 2015
File:
PDF, 239 KB
english, 2015
Conversion to is in progress
Conversion to is failed